Shilpa Medicare · NSE: SHILPAMED · BSE: 530549
Q4 FY21 results · Jan–Mar 2021
Shilpa Medicare reported revenue from operations of ₹208.03 crore (down 5.4% from Q4 FY20) and net profit of ₹7.83 crore (down 77.4% from Q4 FY20) for Q4 FY21 (Jan–Mar 2021), on a consolidated basis.
| Item | Q4 FY21 | Q4 FY20 | YoY | Q3 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 208.03 | 219.99 | −5.4% | 191.25 | +8.8% |
| Other income | 6.91 | 8.91 | −22.4% | 8.61 | −19.7% |
| Total income | 214.94 | 228.90 | −6.1% | 199.85 | +7.5% |
| Profit before tax | 8.40 | 41.57 | −79.8% | 10.58 | −20.6% |
| Net profit for the period | 7.83 | 34.57 | −77.4% | 7.67 | +2.1% |
| EPS, basic (₹) | 0.96 | 4.24 | −77.4% | 0.94 | +2.1% |
| Net margin (%) | 3.8 | 15.7 | 4.0 |
| Item | Q4 FY21 | Q4 FY20 | YoY | Q3 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 179.70 | 197.93 | −9.2% | 171.30 | +4.9% |
| Other income | 15.14 | 2.97 | +409.6% | 8.61 | +75.9% |
| Total income | 194.84 | 200.90 | −3.0% | 179.91 | +8.3% |
| Profit before tax | 35.22 | 37.26 | −5.5% | 24.87 | +41.6% |
| Net profit for the period | 26.59 | 57.90 | −54.1% | 16.88 | +57.5% |
| EPS, basic (₹) | 3.26 | 7.10 | −54.1% | 2.07 | +57.5% |
| Net margin (%) | 14.8 | 29.3 | 9.9 |
Consolidated
- Filed with BSE
- 01 Jun 2021, 14:09 IST
- Board meeting
- 31 May 2021
- Period
- 01 Jan 2021 to 31 Mar 2021
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 01 Jun 2021, 14:09 IST
- Board meeting
- 31 May 2021
- Period
- 01 Jan 2021 to 31 Mar 2021
- Review status
- Audited
- Source
- XBRL filing on BSE